CLINICAL_TRIALS
trial_result
· 2015-04-23
Clinical Trial Update: Ranolazine and Pulmonary Hypertension [Phase 3]
Summary
Phase 3 trial update reporting completed results for ranolazine in patients with angina and pulmonary arterial hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Angina, Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2015-04-23